Alpha Teknova, Inc.

TKNO Nasdaq CIK: 0001850902

Company Information

Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 2451 BERT DRIVE, HOLLISTER, CA, 95023
Mailing Address 2451 BERT DRIVE, HOLLISTER, CA, 95023
Phone 8316371100
Fiscal Year End 1231
EIN 943368109

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
10-K Annual financial report March 2, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC
10-Q Quarterly financial report November 7, 2025 View on SEC
8-K Current report of material events November 6, 2025 View on SEC
10-Q Quarterly financial report August 8, 2025 View on SEC
8-K Current report of material events August 7, 2025 View on SEC
S-3 Shelf registration for future offerings July 10, 2025 View on SEC

Annual Reports

10-K March 2, 2026
  • Specializes in providing critical reagents and media for the high-growth life sciences industry, including cell and gene therapy.
  • Competitive strategy centers on specialized expertise, product quality, reliability, customization, and strong customer relationships.
View Analysis

Insider Trading

BUY 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2835)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.